Cargando…

High CHAF1A Expression Levels Are Positively-Correlated with PD-L1 Expression and Indicate Poor Prognosis in Gastric Cancer

OBJECTIVE: The aim of this study was to analyze the association between the expression of chromatin assembly factor 1 subunit A (CHAF1A) in gastric cancer (GC) and clinicopathological features, disease prognosis, and expression of programmed cell death-ligand 1 (PD-L1). Material and Methods. A total...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bao, Zhehan, Zhang, Yanqiang, Yu, Pengcheng, Wang, Yi, Hu, Can, Xia, Yuhang, Yuan, Li, Xu, Zhiyuan, Cheng, Xiangdong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325625/ https://www.ncbi.nlm.nih.gov/pubmed/35911136 http://dx.doi.org/10.1155/2022/1323321

Ejemplares similares

Retracted: High CHAF1A Expression Levels Are Positively-Correlated with PD-L1 Expression and Indicate Poor Prognosis in Gastric Cancer
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

High HDAC5 expression correlates with a poor prognosis and the tumor immune microenvironment in gastric cancer
por: Yuan, Li, et al.
Publicado: (2022)

SFRP4 Is a Potential Biomarker for the Prognosis and Immunotherapy for Gastric Cancer
por: Yu, Pengcheng, et al.
Publicado: (2022)

Overexpression of CHAF1A is associated with poor prognosis, tumor immunosuppressive microenvironment and treatment resistance
por: Sun, Xia, et al.
Publicado: (2023)

Preoperative chemotherapy combined with para-aortic lymph node dissection has clinical value in the treatment of gastric cancer with para-aortic lymph node metastases
por: Yu, Pengcheng, et al.
Publicado: (2022)

Prognostic significance of serum tumor marker normalization in the perioperative period for patients with advanced gastric cancer
por: Hu, Can, et al.
Publicado: (2022)

High expression of ceramide synthase 5 predicts a poor prognosis in gastric cancer
por: Zhang, Shengjie, et al.
Publicado: (2022)

Prognostic significance of inflammatory and nutritional markers in perioperative period for patients with advanced gastric cancer
por: Zhang, Ruolan, et al.
Publicado: (2023)

CHAF1A interacts with TCF4 to promote gastric carcinogenesis via upregulation of c-MYC and CCND1 expression
por: Zheng, Lixin, et al.
Publicado: (2018)

Low STYK1 expression indicates poor prognosis in gastric cancer
por: Fang, Jian, et al.
Publicado: (2018)

High expression of fibronectin 1 indicates poor prognosis in gastric cancer
por: Sun, Yang, et al.
Publicado: (2020)

A Novel Method for Dynamically Assessing the Prognosis of Patients with pT1 Gastric Cancer: A Large Population-Based Dynamic Prognostic Analysis
por: Pan, Siwei, et al.
Publicado: (2023)

Co-expression of AFAP1-AS1 and PD-1 predicts poor prognosis in nasopharyngeal carcinoma
por: Tang, Yanyan, et al.
Publicado: (2017)

Oncogenic potential of CHAF1A in gastric cancer: A novel link with Helicobacter pylori-driven carcinogenesis?
por: Camilo, Vânia, et al.
Publicado: (2018)

TLR4 expression correlated with PD-L1 expression indicates a poor prognosis in patients with peripheral T-cell lymphomas
por: Zhao, Shu, et al.
Publicado: (2019)

CHAF1A/B mediate silencing of unintegrated HIV-1 DNAs early in infection
por: Geis, Franziska K., et al.
Publicado: (2022)

PD-1 and PD-L1 co-expression predicts favorable prognosis in gastric cancer
por: Wu, Yanhua, et al.
Publicado: (2017)

Tumor Infiltrating PD1-Positive Lymphocytes and the Expression of PD-L1 Predict Poor Prognosis of Soft Tissue Sarcomas
por: Kim, Jung Ryul, et al.
Publicado: (2013)

Targeting CHAF1B Enhances IFN Activity against Myeloproliferative Neoplasm Cells
por: Saleiro, Diana, et al.
Publicado: (2023)

HDAC10 Is Positively Associated With PD-L1 Expression and Poor Prognosis in Patients With NSCLC
por: Liu, Xiaomei, et al.
Publicado: (2020)

PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups
por: Schmidt, Lars Henning, et al.
Publicado: (2015)

MZB1 expression indicates poor prognosis in estrogen receptor-positive breast cancer
por: Watanabe, Manabu, et al.
Publicado: (2020)

Low PARP-1 expression level is an indicator of poor prognosis in patients with stage II and III gastric cancer
por: Park, Song Ee, et al.
Publicado: (2022)

CHAF1A Blocks Neuronal Differentiation and Promotes Neuroblastoma Oncogenesis via Metabolic Reprogramming
por: Tao, Ling, et al.
Publicado: (2021)

Repression of TRIM13 by chromatin assembly factor CHAF1B is critical for AML development
por: Dean, Sarai T., et al.
Publicado: (2023)

Ubiquitin ligase CHAF1B induces cisplatin resistance in lung adenocarcinoma by promoting NCOR2 degradation
por: Gong, Lian, et al.
Publicado: (2020)

High Hepsin expression predicts poor prognosis in Gastric Cancer
por: Zhang, Mingming, et al.
Publicado: (2016)

High Expression of Serine Hydroxymethyltransferase 2 Indicates Poor Prognosis of Gastric Cancer Patients
por: Shi, Haihong, et al.
Publicado: (2019)

LAMB1 Is Related to the T Stage and Indicates Poor Prognosis in Gastric Cancer
por: Ran, Tao, et al.
Publicado: (2021)

Increased PD-1-positive macrophages in the tissue of gastric cancer are closely associated with poor prognosis in gastric cancer patients
por: Kono, Yusuke, et al.
Publicado: (2020)

CD3D Is an Independent Prognostic Factor and Correlates With Immune Infiltration in Gastric Cancer
por: Yuan, Li, et al.
Publicado: (2022)

Upregulation of PD-L1 and APE1 is associated with tumorigenesis and poor prognosis of gastric cancer
por: Qing, Yi, et al.
Publicado: (2015)

Low expression of CDK5RAP3 and DDRGK1 indicates a poor prognosis in patients with gastric cancer
por: Lin, Jian-Xian, et al.
Publicado: (2018)

Elevated LSD1 and SNAIL Expression Indicate Poor Prognosis in Hypopharynx Carcinoma
por: Bottner, Justus, et al.
Publicado: (2022)

PD-L1 expression indicates favorable prognosis for advanced lung adenocarcinoma patients treated with pemetrexed
por: Zhang, Pei, et al.
Publicado: (2017)

The Autophagy Related Gene CHAF1B Is a Relevant Prognostic and Diagnostic Biomarker in Hepatocellular Carcinoma
por: Zhang, Zunni, et al.
Publicado: (2021)

Long non-coding RNA lnc-CHAF1B-3 as a new player in fibrosis
por: Sen, Ilayda, et al.
Publicado: (2023)

TBL1XR1 Is Highly Expressed in Gastric Cancer and Predicts Poor Prognosis
por: Liu, Fang, et al.
Publicado: (2016)

Positive expression of ZNF689 indicates poor prognosis of hepatocellular carcinoma
por: Yi, Peng Sheng, et al.
Publicado: (2018)

Decreased Expression of AZGP1 Is Associated with Poor Prognosis in Primary Gastric Cancer
por: Huang, Chun-yu, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_5ihsnh3jp9dvftnmjih1405vmg